| |
Alan G. Walton, Ph.D., D.Sc.
Senior General Partner
Westport, CT
awalton@oxbio.com |
Dr. Walton joined Oxford as a General Partner in 1987. Previously, he was President and CEO of University Genetics Co., a public biotechnology company involved in technology transfer and seed investments in university-related projects. Prior to University Genetics, he taught at several prestigious institutions including Harvard Medical School, Indiana University and Case Western Reserve where he was Professor of Macromolecular Science and Director of the Laboratory for Biological Macromolecules. Dr. Walton received his Ph.D. in chemistry and a D.Sc. in biological chemistry from the University of Nottingham in England. In addition to serving as the author of more than 130 scientific articles, books and chapters, Dr. Walton holds patents in the fields of molecular biology and biotechnology. Dr. Walton serves on the Boards of Acadia Pharmaceuticals, Alexandria Real Estate Equities and Advanced Cell Technology, Inc. He is also on the Board of Research!America, a philanthropic organization. Dr. Walton was a founder of Human Genome Sciences and GeneLogic and is the Founding Chairman of the Biotechnology Venture Investors Group. In 2005 he received an honorary Doctor of Laws degree (LLD) from the University of Nottingham for lifetime achievements in the Life Sciences and in 2007 was appointed Distinguished Adjunct University Professor at Case Western Reserve University.
Back to OBP Team
|
|